Nurix Therapeutics (NRIX) Net Margin (2019 - 2026)
Nurix Therapeutics (NRIX) posted Net Margin of 81.69% for fiscal Q3 2026 (quarter ended Aug 31, 2026), up 1176.46 percentage points from -1094.77% a year earlier and up 1071.79 percentage points from the prior quarter.
Nurix Therapeutics (NRIX) Net Margin (2019 - 2026) Analysis & Trends
For the trailing twelve months through Aug 31, 2026, Net Margin at Nurix Therapeutics was 42.01%, up 334.51 percentage points year-over-year; for FY2025 (ended Nov 30, 2025), it came in at -314.90%, up 39.95 percentage points from FY2024.
- Annual Net Margin shows a five-year change of -72.24 percentage points (FY2020 to FY2025).
- In prior fiscal years, Nurix Therapeutics' Net Margin was -354.85% in FY2024 (-167.88 pp), -186.98% in FY2023 (+279.95 pp), -466.93% in FY2022 (-73.00 pp) and -393.93% in FY2021 (-151.27 pp).
- The fiscal Q3 2026 figure stands as the highest quarterly Net Margin since fiscal Q2 2020.
- On a year-over-year basis, Net Margin increased in two of the last eight quarters, with an average year-over-year change of -199.31 percentage points.
- The strongest year-over-year quarter for Net Margin in the past five years was fiscal Q3 2026, with a gain of 1176.46 percentage points; the weakest was fiscal Q1 2026, with a drop of 1088.96 percentage points.
- According to Business Quant data, Net Margin for the three prior fiscal quarters was -990.10% (Q2 2026), -1394.34% (Q1 2026) and -576.13% (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 30.88% |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 0.83% |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 21.27% |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | -8.04% |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 22.65% |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 16.30% |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 23.62% |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | -134.51% |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | -1.65% |
| 10 | Nurix Therapeutics | 2.84 Bn | 215.50 Mn | - | 81.69% |
Historic Data
| Date | Value |
|---|---|
| Aug 31, 2026 | 81.69% |
| May 31, 2026 | -990.10% |
| Feb 28, 2026 | -1,394.34% |
| Nov 30, 2025 | -576.13% |
| Aug 31, 2025 | -1,094.77% |
| May 31, 2025 | -98.66% |
| Feb 28, 2025 | -305.38% |
| Nov 30, 2024 | -440.75% |
| Aug 31, 2024 | -388.91% |
| May 31, 2024 | -368.39% |
| Feb 29, 2024 | -250.33% |
| Nov 30, 2023 | -276.77% |
| Aug 31, 2023 | -200.26% |
| May 31, 2023 | -79.14% |
| Feb 28, 2023 | -321.11% |
| Nov 30, 2022 | -688.74% |
| Aug 31, 2022 | -423.58% |
| May 31, 2022 | -397.14% |
| Feb 28, 2022 | -442.09% |
| Nov 30, 2021 | -509.76% |
Nurix Therapeutics Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=NRIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "NRIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=NRIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();